Alzheimer's is Everywhere
behold there's a front-page, above-the-fold piece under the headline, "Taking On Alzheimer's". That night while watching the first hour of the Tony's on CBS before switching over to HBO to watch Tony (count me among those who thought their TV went on the fritz at the end) I saw a promo for an Alzheimer's story on the Monday "CBS Evening News". Then yesterday the new "Newsweek" hits the newsstand. And guess what's on the cover? You got it. "Caregiving & Alzheimer's".
And then this morning I open my hotel-room door to get the free "USA Today" dropped on the threshold and staring up at me is the front-page, above-the-fold headline, "The young face of Alzheimer's."
Kris Jenner who manages the Health Sciences Fund for T. Rowe Price says there is no greater opportunity in big pharma right now than Alzheimer's. Some analysts think if the major drug companies and biotechs working on Alzheimer's treatments--dare I say, cures--are successful that the segment could explode from a $1 billion business today to as much as a $15 billion business over the next several years.
With that kind of money at stake and the challenge of addressing the overwhelming new estimates about the rapidly rising prevalence of Alzheimer's, let's hope the ubiquitous media coverage this week isn't just a flash in the pan.
Questions? Comments? Pharma@cnbc.com